CCNA2和NEK2通过向细胞周期来调节质母细胞瘤的进展
Hao-Yu Zhou1, Yi-Chang Wang1, Tuo Wang1
1Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
环素A2 (CCNA2) 和NIMA相关激酶2 (NEK2) 的高表达与质母细胞瘤的不良结果相关. 这些基因在增殖前代细胞中升级调节,表明质母细胞瘤 (GBM) 的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 质母细胞瘤 (GBM) 呈现出显著的异质性,导致患者的生存率不佳,尽管进行了全面的治疗.
- 环素A2 (CCNA2) 和NIMA相关激酶2 (NEK2) 在GBM病原体中的作用需要进一步阐明.
研究的目的:
- 研究CCNA2和NEK2在GBM中的分子机制和预后意义.
- 通过单细胞测序,探索CCNA2和NEK2在GBM子集中的表达模式.
- 开发一个对GBM患者生存率的预测模型.
主要方法:
- 使用公共数据库 (GEO,KEGG) 对CCNA2和NEK2表达和质瘤预后的生物信息分析.
- 单细胞测序 (伪时间和三循环分析) 来确定GBM子集中的基因分布.
- 西方斑点和免疫组织化学染色用于验证.
- 用于信号通路的丰富分析和用于生存预测的名ogram构造.
主要成果:
- 质瘤中高CCNA2和NEK2表达与不良的临床结果有关.
- 单细胞分析揭示了CCNA2和NEK2在GBM内增殖的阳性神经原生细胞 (P-NPCs) 中的上调,可能激活G2M检查点通路.
- 一个包含P-NPCs,年龄和治疗得分的nomogram准确地预测了GBM生存概率.
结论:
- CCNA2和NEK2通过调节细胞循环来促进质母细胞瘤的进展.
- 准CCNA2和NEK2为GBM提供了一个潜在的新疗法策略.
更多相关视频
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
09:51Assessing Cell Cycle Progression of Neural Stem and Progenitor Cells in the Mouse Developing Brain after Genotoxic Stress
Published on: May 7, 2014
相关概念视频
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of Cdk Activity
Negative Regulator Molecules
Mitogens and the Cell Cycle
